Is 18F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?

Authors

  • Marina Orevi Department of Medical Biophysics and Nuclear Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • Nanette Freedman Department of Medical Biophysics and Nuclear Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • Esther Tahover Department of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • Beatrice Uziely Department of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • Roland Chisin Department of Medical Biophysics and Nuclear Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • Tamar Peretz Department of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
  • Martine Klein Department of Medical Biophysics and Nuclear Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel

DOI:

https://doi.org/10.3109/0284186X.2015.1054952

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2016-02-01

How to Cite

Orevi, M., Freedman, N., Tahover, E., Uziely, B., Chisin, R., Peretz, T., & Klein, M. (2016). Is 18F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?. Acta Oncologica, 55(2), 244–247. https://doi.org/10.3109/0284186X.2015.1054952

Issue

Vol. 55 No. 2 (2016): Acta Oncologica

Section

Articles